Federal Panel Alters Hepatitis B Vaccine Guidelines for Newborns

A federal vaccine advisory panel has voted to change its longstanding recommendation regarding the hepatitis B vaccine for newborns. On March 15, 2024, the Advisory Committee on Immunization Practices (ACIP) decided to discontinue the universal vaccination of all infants at birth, a guideline that has been in place for over three decades.

The committee’s new stance, approved by an 8-3 vote, maintains vaccination for infants born to mothers who test positive for hepatitis B or whose status is unknown. However, it now allows mothers who test negative to discuss the necessity of the vaccine with their healthcare providers. This decision has raised concerns among public health experts who fear it could lead to an increase in hepatitis B infections.

Neil Maniar, director of the Master of Public Health program at Northeastern University, expressed deep concern over the potential impact of this change. He highlighted that the hepatitis B vaccine has demonstrated high safety and efficacy rates over its 30-year history. “Since we implemented the hepatitis B vaccine recommendation, we’ve probably reduced the likelihood of liver cancer in infants and young children by about 95%,” he noted.

The World Health Organization reported that in 2022, approximately 254 million individuals globally were living with chronic hepatitis B, with around 1.2 million new infections each year. In the United States, the Centers for Disease Control and Prevention (CDC) reported 17,650 new chronic cases in 2023 and an estimated 14,400 new acute cases. Experts like Maniar argue that the change in guidelines could reverse advancements made in reducing hepatitis B infections and related complications.

Concerns Over Health Access and Risks

Public health law expert Wendy Parmet raised additional concerns about the accessibility of the vaccine following the new recommendation. She stated that removing the initial dose from the hospital setting could hinder access for families, particularly those who may face financial barriers or lack transportation to medical appointments. “It will require more medical appointments, and not everybody has access to or can afford to go to a pediatrician,” Parmet explained.

Critics of the decision have also pointed fingers at recent changes within the ACIP. They argue that Robert F. Kennedy Jr., the Secretary of Health and Human Services, has influenced the committee’s direction after replacing several members with individuals skeptical of vaccinations. Under Kennedy’s oversight, the CDC has altered its language regarding vaccination and autism, stating that the consensus on vaccines not causing autism “is not an evidence-based claim.”

During the ACIP meeting, Dr. Tracy Beth Hoeg, the acting director of the Center for Drug Evaluation and Research, remarked that the U.S. stands out among high-income nations for recommending a birth dose of the hepatitis B vaccine for infants of mothers who test negative. She acknowledged concerns regarding the reporting of side effects associated with the vaccine, cautioning against the assumption that benefits always outweigh risks.

Potential Consequences for Children

The lack of a universal vaccination policy could put children at increased risk for hepatitis B, which can be transmitted during childbirth, through needle sharing, or even through contact with infected blood on surfaces. Maniar emphasized, “It takes just a couple of droplets of blood to transmit the virus.”

Opposition to the revised recommendation came from Dr. Amy Middleman, a representative of the Society for Adolescent Health and Medicine. She expressed her apprehension about the potential for some children to fall through the cracks of an “imperfect” healthcare system, leading to new infections. “This is the first time in my 21 years as a liaison to ACIP that its policy actually puts children in this country at higher risk rather than lower risk of disease and death,” Middleman stated.

The ACIP now recommends that mothers who test negative for the virus should wait to vaccinate their children until they are at least two months old. This shift marks a significant change in policy that has drawn scrutiny from public health experts who worry about the implications for future generations. As Maniar cautioned, “Once we take our foot off the pedal, we are likely to see an increase in these infections.”

This article is republished courtesy of Northeastern Global News.